PharmaShots | Incisive News in 3 Shots

Subscribe Now

JNJ-78436735

J&J Initiates Global P-III Clinical Study of its COVID-19 Vaccine

J&J Initiates Global P-III Clinical Study of its COVID-19 Vaccine

September 24, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us